ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
0.005
0.00
( 0.00% )
Actualizado: 18:00:00

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.005
Postura de Compra
0.005
Postura de Venta
0.01
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.005 Rango de 52 semanas 0.04
Capitalización de Mercado [m]
Precio Anterior
0.005
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
41,941
Acciones en circulación
132,634,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-0.02
turnover
254k
Beneficio neto
-2.97M

Acerca de Aequus Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Vancouver, British Columbia, Can
Fundado
-
Aequus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker AQS. The last closing price for Aequus Pharmaceuticals was $0.01. Over the last year, Aequus Pharmaceuticals shares have traded in a share price range of $ 0.005 to $ 0.04.

Aequus Pharmaceuticals currently has 132,634,000 shares in issue. The market capitalisation of Aequus Pharmaceuticals is $663,170 . Aequus Pharmaceuticals has a price to earnings ratio (PE ratio) of 0.00.

AQS Últimas noticias

Aequus Reports Second Quarter 2023 Financial Highlights and General Update

VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus...

Aequus Announces Zimed PF Now Available in Canada

VANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announced...

Aequus Announces Zimed PF Website Launch

VANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, are...

Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada

VANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a specialty pharmaceutical company announces...

Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)

VANCOUVER, British Columbia, July 06, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces today it has increased its debt by...

Aequus Provides General Update and First Quarter 2023 Financial Highlights

VANCOUVER, British Columbia, May 30, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus...

Aequus Provides General Update and Fiscal 2022 Financial Results

VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on...

Aequus Grants Stock Options

VANCOUVER, British Columbia, April 19, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announces that it has granted incentive stock...

Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board Update

VANCOUVER, British Columbia, April 05, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), announced today it has entered into a loan...

Aequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)

VANCOUVER, British Columbia, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), is pleased to announce that Health Canada has...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.0050.0050.005286200.005CS
4-0.005-500.010.0150.005779430.00844485CS
12-0.01-66.66666666670.0150.0150.005419410.00802302CS
26-0.015-750.020.0250.005557460.01304811CS
52-0.02-800.0250.040.005850110.01934387CS
156-0.105-95.45454545450.110.110.005672520.03239508CS
260-0.125-96.15384615380.130.290.0051146470.12146652CS

AQS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Aequus Pharmaceuticals?
El precio actual de las acciones de Aequus Pharmaceuticals es $ 0.005
¿Cuántas acciones de Aequus Pharmaceuticals están en circulación?
Aequus Pharmaceuticals tiene 132,634,000 acciones en circulación
¿Cuál es la capitalización de mercado de Aequus Pharmaceuticals?
La capitalización de mercado de Aequus Pharmaceuticals es CAD 663.17k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Aequus Pharmaceuticals?
Aequus Pharmaceuticals ha negociado en un rango de $ 0.005 a $ 0.04 durante el último año
¿Cuál es el ratio de efectivo a ventas de Aequus Pharmaceuticals?
El ratio de efectivo a ventas de Aequus Pharmaceuticals es 0
¿Cuál es la moneda de reporte de Aequus Pharmaceuticals?
Aequus Pharmaceuticals presenta sus resultados financieros en CAD
¿Cuál es el último ingresos anual de Aequus Pharmaceuticals?
El último ingresos anual de Aequus Pharmaceuticals es CAD 254k
¿Cuál es el último beneficio anual de Aequus Pharmaceuticals?
El último beneficio anual de Aequus Pharmaceuticals es CAD -2.97M
¿Cuál es la dirección registrada de Aequus Pharmaceuticals?
La dirección registrada de Aequus Pharmaceuticals es SUITE 2600, 595 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, V7X 1L3
¿Cuál es la dirección del sitio web de Aequus Pharmaceuticals?
La dirección del sitio web de Aequus Pharmaceuticals es www.aequuspharma.ca
¿En qué sector industrial opera Aequus Pharmaceuticals?
Aequus Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BYM.HBaymount Incorporated
$ 0.015
(200.00%)
102k
FBR.HFibre Crown Manufacturing Inc
$ 0.12
(140.00%)
10k
GETTGETT Gold Inc
$ 0.02
(100.00%)
1.1k
CANDCandelaria Mining Corp
$ 0.01
(100.00%)
10k
GBUGabriel Resources Ltd
$ 0.01
(100.00%)
316.73k
GAR.HGreen Arrow Resources Inc
$ 0.02
(-55.56%)
103k
TVITVI Pacific Inc
$ 0.005
(-50.00%)
23.29k
MVYMoovly Media Inc
$ 0.005
(-50.00%)
26k
EKGCardioComm Solutions Inc
$ 0.01
(-50.00%)
79k
AOROAloro Mining Corp
$ 0.01
(-33.33%)
59k
GXUGoviEx Uranium Inc
$ 0.04
(-20.00%)
9.32M
AISXAisix Solutions Inc
$ 0.045
(28.57%)
5.56M
CYGCygnus Metals Limited
$ 0.13
(0.00%)
4.72M
GPUSAlset AI Ventures Inc
$ 0.10
(5.26%)
3.03M
QNCQuantum Emotion Corp
$ 0.80
(5.26%)
2.58M
spdpro spdpro 4 minutos hace
have a good weekend >
laying low > not trading > too much crazy going on
I'll take my small everyday gains in sgov and ignore for now
Myth Myth 4 minutos hace
not enough !

lol....
nowwhat2 nowwhat2 5 minutos hace
They tend to use lots of emojis.....


Lazy people do no work.....They just pump thier bag.....
They use thier phone and pump thier bag.
That is all they do.



https://investorshub.advfn.com/uimage/uploads/2025/1/31/ncbzlBTC_!_31_15d_9
Citrati Citrati 5 minutos hace
Agreed sab63090.
The blue lines form the strongest market structure for support or resistance for quite a distance in either direction. Best case is the top blue line is support. Next best is for the zone to hold as support. Weakest case, price confirmation below the lowest blue line creatin
AVXL
trunkmonk trunkmonk 5 minutos hace
exactly, he wanted to retire as Director. before he was in, he said they should be out by HERA standards. Its possible he owns shares now and does not have to declare anything. He bends with the wind, and im sure he wants to make some good bread too.
ducci1 ducci1 5 minutos hace
Looks like Mkt hang around Da Red Line & Pivot! --- In /Out Rest Day !!LOL!!
SPY
Carjockey2 Carjockey2 5 minutos hace
What in the wild wild world of sports is going on??

614 million x 88 million

.0006 x. .0007
HMBL
crazy horse 0 crazy horse 0 6 minutos hace
New Evidence for the Authenticity of the Shroud of Turin: Digging for Truth Episodes 248/249

https://www.youtube.com/watch?v=6y3zKsxtAEo
TightCoil TightCoil 6 minutos hace
Agreed - his remark (about Navy being
associated to the Wash DC crash is
about as sick as it gets
FNMA
nagoya1 nagoya1 6 minutos hace
Getting all my fiery GSE posts in before the weekend system update.
Ah yes, keep on riding the donkeys, gse pref loving ky 0.05 morons.
Fnma
FNMA
Filterthenoise Filterthenoise 6 minutos hace
🐍 triggered by my shares
RNVA
gp22 gp22 7 minutos hace
$OSS: AI Edge Computing play. Got trounced in DeepSeek hoax nonsense. Was breaking out last week when AI Sector hit, even though $OSS has nothing to do with that issue....Moving back up now.
OSS
trunkmonk trunkmonk 7 minutos hace
that is a good way to expedite the process. although he gave one to Mnuchin at the beginning of his last term in office, the order was not to release but to assess it. Now we know its ready to release by any standards of normal people, and Trump wont waste his time with anything but an Executive ord
FMCC
urge2surge urge2surge 7 minutos hace
Chart technicals are stellar. Impressive and foreboding to higher highs.
https://stockcharts.com/sc3/ui/?s=FDCT
FDCT
fourcloze fourcloze 7 minutos hace
Revoked yet?? LOLOLOLOL

-OUT-
DBMM
DavidLeeRoth DavidLeeRoth 7 minutos hace
Heavy hitter investing a lot in ASII😎 Gotta love that!!
ASII
ALTOGETHER ALTOGETHER 7 minutos hace
Nothing has changed I believe. Just weeding out the people who want a fast buck instead of walking this one through.
We'll see....................
HIRU
gp22 gp22 7 minutos hace
$OSS: AI Edge Computing play. Got trounced in DeepSeek hoax nonsense. Was breaking out last week when AI Sector hit, even though $OSS has nothing to do with that issue....Moving back up now.
OSS
Louie_Louie Louie_Louie 8 minutos hace
You know also Trunk, the idiots arguing about Calabria on FNMA...The reasoning is very simple why his tune has changed. He knew when he was in control that release meant he was unemployed, so he became a swamp creature, because that's all the swamp folk in DC care about is either preserving their p
BIOCHEMUP BIOCHEMUP 8 minutos hace
I'm in. Looks good.
TSSI
Chartmaster Chartmaster 8 minutos hace
RDAR Raadr (Doing Business as Telvantis) Unlocks Exclusive Benefits for Long-Term Shareholders With New Ambassador Program

NEW YORK - January 31, 2025 (NEWMEDIAWIRE) - Raadr Inc., now doing business as Telvantis (OTC PINK: RDAR), a rapidly expanding US-based telecommunications compan
RDAR
gp22 gp22 8 minutos hace
$OSS: AI Edge Computing play. Got trounced in DeepSeek hoax nonsense. Was breaking out last week when AI Sector hit, even though $OSS has nothing to do with that issue....Moving back up now.
OSS
nyheat nyheat 8 minutos hace
SES is ticking up nicelyyyyy
SES
MDA MDA 8 minutos hace
242+ Million Sells
1.5 Million Buys

Stop lying here and on every board you post on.
You really should be reported.
HCMC

Su Consulta Reciente

Delayed Upgrade Clock